NEU.AX Overview

Company Profile

Related stocks

PYC.AX • Australia

PYC THERAP FPO [PYC]

2.45 AUD

1.68B USD 1Y +109.4%

ONESOURCE.NS • India

ONESOURCE SPECL PHARMA L

1,461.3 INR

1.73B USD 1Y -22.7%

310210.KQ • South Korea

VRNI

138,400 KRW

1.9B USD 1Y -19.1%

MSB.AX • Australia

MESOBLAST FPO [MSB]

2 AUD

1.81B USD 1Y -32.2%

MESO • Australia

Mesoblast Limited

14.29 USD

1.86B USD 1Y -30.4%

9606.HK • China

DUALITYBIO-B

182.7 HKD

2.13B USD 1Y -42.1%

2595.HK • China

GENFLEET-B

28.6 HKD

1.4B USD 1Y -21%

1952.HK • China

EVEREST MED

29.6 HKD

1.33B USD 1Y -47.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

70.6% p.a.

Max Drawdown (5Y)

-65.3%

Sharpe Ratio (5Y)

0.78

Beta Factor

1.57

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

High market risk: Beta of 1.57 indicates above-average volatility compared to the broader market.

🔴 High valuation risk: Avg P/E of 134.7 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (70.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -72.8% in the extended horizon.